Merdury Biopharmaceutical Corporation (TPEX:6932)
6.27
-0.22 (-3.39%)
Jun 18, 2026, 2:54 PM CST
-44.27% (1Y)
| Market Cap | 2.65B -50.6% |
| Revenue (ttm) | n/a |
| Net Income | -67.23M |
| EPS | -0.16 |
| Shares Out | 422.03M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 278,464 |
| Open | 6.49 |
| Previous Close | 6.49 |
| Day's Range | 6.27 - 6.59 |
| 52-Week Range | 4.95 - 12.50 |
| Beta | -1.29 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 10, 2026 |